Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong
- PMID: 32124000
- PMCID: PMC7087729
- DOI: 10.1007/s00417-020-04641-8
Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong
Abstract
Purpose: Coronavirus disease (COVID-19) has rapidly emerged as a global health threat. The purpose of this article is to share our local experience of stepping up infection control measures in ophthalmology to minimise COVID-19 infection of both healthcare workers and patients.
Methods: Infection control measures implemented in our ophthalmology clinic are discussed. The measures are based on detailed risk assessment by both local ophthalmologists and infection control experts.
Results: A three-level hierarchy of control measures was adopted. First, for administrative control, in order to lower patient attendance, text messages with an enquiry phone number were sent to patients to reschedule appointments or arrange drug refill. In order to minimise cross-infection of COVID-19, a triage system was set up to identify patients with fever, respiratory symptoms, acute conjunctivitis or recent travel to outbreak areas and to encourage these individuals to postpone their appointments for at least 14 days. Micro-aerosol generating procedures, such as non-contact tonometry and operations under general anaesthesia were avoided. Nasal endoscopy was avoided as it may provoke sneezing and cause generation of droplets. All elective clinical services were suspended. Infection control training was provided to all clinical staff. Second, for environmental control, to reduce droplet transmission of COVID-19, installation of protective shields on slit lamps, frequent disinfection of equipment, and provision of eye protection to staff were implemented. All staff were advised to measure their own body temperatures before work and promptly report any symptoms of upper respiratory tract infection, vomiting or diarrhoea. Third, universal masking, hand hygiene, and appropriate use of personal protective equipment (PPE) were promoted.
Conclusion: We hope our initial experience in stepping up infection control measures for COVID-19 infection in ophthalmology can help ophthalmologists globally to prepare for the potential community outbreak or pandemic. In order to minimise transmission of COVID-19, ophthalmologists should work closely with local infection control teams to implement infection control measures that are appropriate for their own clinical settings.
Keywords: COVID-19; Coronavirus; Hong Kong; Infection control; Ophthalmology; SARS-CoV-2.
Conflict of interest statement
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Figures
Comment in
-
Ocular manifestation, eye protection, and COVID-19.Graefes Arch Clin Exp Ophthalmol. 2020 Jun;258(6):1339. doi: 10.1007/s00417-020-04662-3. Epub 2020 Mar 30. Graefes Arch Clin Exp Ophthalmol. 2020. PMID: 32232568 Free PMC article. No abstract available.
-
Protective shields for ophthalmic equipment to minimise droplet transmission of COVID-19.Graefes Arch Clin Exp Ophthalmol. 2020 Jul;258(7):1571-1573. doi: 10.1007/s00417-020-04683-y. Epub 2020 Apr 22. Graefes Arch Clin Exp Ophthalmol. 2020. PMID: 32322964 Free PMC article. No abstract available.
-
Implications of COVID-19 for uveitis patients: perspectives from Hong Kong.Eye (Lond). 2020 Jul;34(7):1163-1164. doi: 10.1038/s41433-020-0905-1. Epub 2020 Apr 29. Eye (Lond). 2020. PMID: 32350447 Free PMC article. No abstract available.
References
-
- WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. (2020) World Health Organization. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at.... Accessed 18 Feb 2020
-
- COVID-19. (2020) World Health Organization. https://www.ecdc.europa.eu/en/novel-coronavirus-china. Accessed 18 Feb 2020
-
- Symptoms of Coronavirus Disease 2019. (2020) Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html. Accessed 16 Feb 2020
-
- Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, Liu L, Shan H, Lei C-L, Hui DS, Du B, Li L-J, Zeng G, Yuen K-Y, Chen R-C, Tang C-L, Wang T, Chen P-Y, Xiang J, Li S-Y, Wang J-L, Liang Z-J, Peng Y-X, Wei L, Liu Y, Hu Y-H, Peng P, Wang J-M, Liu J-Y, Chen Z, Li G, Zheng Z-J, Qiu S-Q, Luo J, Ye C-J, Zhu S-Y, Zhong N-S (2020) Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv:2020.2002.2006.20020974. 10.1101/2020.02.06.20020974
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous